AAAAAA
Results: 651-675/860
Authors:
HOSSAIN MM
NAKAYAMA H
GOTO N
Citation: Mm. Hossain et al., APOPTOSIS IN THE CENTRAL-NERVOUS-SYSTEM OF DEVELOPING MOUSE FETUSES FROM 5-AZACYTIDINE-ADMINISTERED DAMS, Toxicologic pathology, 23(3), 1995, pp. 367-372
Authors:
WESTWOOD FR
DUFFY PA
MALPASS DA
JONES HB
TOPHAM JC
Citation: Fr. Westwood et al., DISTURBANCE OF MACROPHAGE AND MONOCYTE FUNCTION IN THE DOG BY A THROMBOXANE RECEPTOR ANTAGONIST - ICI-185,282, Toxicologic pathology, 23(3), 1995, pp. 373-384
Authors:
KATO M
TAKADA S
KASHIDA Y
NOMURA M
Citation: M. Kato et al., HISTOLOGICAL EXAMINATION ON ACHILLES-TENDON LESIONS INDUCED BY QUINOLONE ANTIBACTERIAL AGENTS IN JUVENILE RATS, Toxicologic pathology, 23(3), 1995, pp. 385-392
Authors:
TRYPHONAS L
CLEMENT JG
Citation: L. Tryphonas et Jg. Clement, HISTOMORPHOGENESIS OF SOMAN-INDUCED ENCEPHALOCARDIOMYOPATHY IN SPRAGUE-DAWLEY RATS, Toxicologic pathology, 23(3), 1995, pp. 393-409
Authors:
WHEELDON EB
WILLIAMS SM
SOAMES AR
JAMES NH
ROBERTS RA
Citation: Eb. Wheeldon et al., QUANTITATION OF APOPTOTIC BODIES IN RAT-LIVER BY IN-SITU END LABELING(ISEL) - CORRELATION WITH MORPHOLOGY, Toxicologic pathology, 23(3), 1995, pp. 410-415
Authors:
OWEN RA
MOLONNOBLOT S
HUBERT MF
KINDT MV
KEENAN KP
EYDELLOTH RS
Citation: Ra. Owen et al., THE MORPHOLOGY OF JUXTAGLOMERULAR CELL HYPERPLASIA AND HYPERTROPHY INNORMOTENSIVE RATS AND MONKEYS GIVEN AN ANGIOTENSIN-II RECEPTOR ANTAGONIST (VOL 22, PG 606, 1994), Toxicologic pathology, 23(3), 1995, pp. 606-619
Authors:
CAYEN MN
BLACK HE
Citation: Mn. Cayen et He. Black, 13TH INTERNATIONAL-SYMPOSIUM OF THE SOCIETY OF TOXICOLOGIC PATHOLOGISTS, ROLE OF DRUG-METABOLISM AND PHARMACOKINETICS IN TOXICOLOGIC PATHOLOGY JUNE 5-9, 1994 AT THE OMNI-HOTEL AT CHARLESTON-PLACE, CHARLESTON, SOUTH-CAROLINA - INTRODUCTION, Toxicologic pathology, 23(2), 1995, pp. 97-97
Authors:
CALDWELL J
GARDNER I
SWALES N
Citation: J. Caldwell et al., AN INTRODUCTION TO DRUG DISPOSITION - THE BASIC PRINCIPLES OF ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, Toxicologic pathology, 23(2), 1995, pp. 102-114
Authors:
BENET LZ
ZIAAMIRHOSSEINI P
Citation: Lz. Benet et P. Ziaamirhosseini, BASIC PRINCIPLES OF PHARMACOKINETICS, Toxicologic pathology, 23(2), 1995, pp. 115-123
Authors:
CHIU SHL
THOMPSON KA
VINCENT SH
ALVARO RF
HUSKEY SEW
STEARNS RA
PETTIBONE DJ
Citation: Shl. Chiu et al., THE ROLE OF DRUG-METABOLISM IN DRUG DISCOVERY - A CASE-STUDY IN THE SELECTION OF AN OXYTOCIN RECEPTOR ANTAGONIST FOR DEVELOPMENT, Toxicologic pathology, 23(2), 1995, pp. 124-130
Authors:
MIWA GT
Citation: Gt. Miwa, GOALS, DESIGN, TIMING, AND FUTURE OPPORTUNITIES FOR NONCLINICAL DRUG-METABOLISM STUDIES, Toxicologic pathology, 23(2), 1995, pp. 131-135
Authors:
COHEN SM
ELLWEIN LB
Citation: Sm. Cohen et Lb. Ellwein, RELATIONSHIP OF DNA-ADDUCTS DERIVED FROM 2-ACETYLAMINOFLUORENE TO CELL-PROLIFERATION AND THE INDUCTION OF RODENT LIVER AND BLADDER-TUMORS, Toxicologic pathology, 23(2), 1995, pp. 136-142
Authors:
WELLING PG
Citation: Pg. Welling, DIFFERENCES BETWEEN PHARMACOKINETICS AND TOXICOKINETICS, Toxicologic pathology, 23(2), 1995, pp. 143-147
Authors:
CAYEN MN
Citation: Mn. Cayen, CONSIDERATIONS IN THE DESIGN OF TOXICOKINETIC PROGRAMS, Toxicologic pathology, 23(2), 1995, pp. 148-157
Authors:
BATRA VK
Citation: Vk. Batra, TOXICOKINETICS TOXICODYNAMIC CORRELATIONS - GOALS, METHODS, AND LIMITATIONS/, Toxicologic pathology, 23(2), 1995, pp. 158-164
Authors:
MAYER PR
Citation: Pr. Mayer, ABSORPTION, METABOLISM, AND OTHER FACTORS THAT INFLUENCE DRUG EXPOSURE IN TOXICOLOGY STUDIES, Toxicologic pathology, 23(2), 1995, pp. 165-169
Authors:
DAHLEM AM
ALLERHEILIGEN SR
VODICNIK MJ
Citation: Am. Dahlem et al., CONCOMITANT TOXICOKINETICS - TECHNIQUES FOR AND INTERPRETATION OF EXPOSURE DATA OBTAINED DURING THE CONDUCT OF TOXICOLOGY STUDIES, Toxicologic pathology, 23(2), 1995, pp. 170-178
Authors:
TAKACS AR
Citation: Ar. Takacs, ANCILLARY APPROACHES TO TOXICOKINETIC EVALUATIONS, Toxicologic pathology, 23(2), 1995, pp. 179-186
Authors:
MONRO A
MORDENTI J
Citation: A. Monro et J. Mordenti, EXPRESSION OF EXPOSURE IN NEGATIVE CARCINOGENICITY STUDIES - DOSE BODY WEIGHT, DOSE/BODY SURFACE-AREA, OR PLASMA-CONCENTRATIONS/, Toxicologic pathology, 23(2), 1995, pp. 187-198
Authors:
WRIGHTON SA
RING BJ
VANDENBRANDEN M
Citation: Sa. Wrighton et al., THE USE OF IN-VITRO METABOLISM TECHNIQUES IN THE PLANNING AND INTERPRETATION OF DRUG SAFETY STUDIES, Toxicologic pathology, 23(2), 1995, pp. 199-208
Authors:
CLEMENT RP
Citation: Rp. Clement, PRECLINICAL DRUG-METABOLISM PROGRAMS FOR FOOD-PRODUCING ANIMALS, Toxicologic pathology, 23(2), 1995, pp. 209-216
Authors:
CAYEN MN
Citation: Mn. Cayen, TOXICOKINETIC CHALLENGES IN THE PHARMACEUTICAL-INDUSTRY, Toxicologic pathology, 23(2), 1995, pp. 217-219
Authors:
DEGEORGE JJ
Citation: Jj. Degeorge, FOOD-AND-DRUG-ADMINISTRATION VIEWPOINTS ON TOXICOKINETICS - THE VIEW FROM REVIEW, Toxicologic pathology, 23(2), 1995, pp. 220-225
Authors:
WARD JM
HARDISTY JF
HAILEY JR
STREETT CS
Citation: Jm. Ward et al., PEER-REVIEW IN TOXICOLOGIC PATHOLOGY, Toxicologic pathology, 23(2), 1995, pp. 226-234
Authors:
STEFANSKI SA
GREENWELL A
MERRICK BA
BROWN TT
REYNOLDS SH
Citation: Sa. Stefanski et al., PROLIFERATING CELL NUCLEAR ANTIGEN STAINING OF FISCHER-344 N RAT SPLEENS AFFECTED BY LARGE GRANULAR LYMPHOCYTE LEUKEMIA/, Toxicologic pathology, 23(1), 1995, pp. 1-6